Spina Bifida Clinical Trials 2022

Browse 19 Spina Bifida Medical Studies Across 23 Cities

32 Spina Bifida Clinics

Reviewed by Michael Gill, B. Sc.
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

Robotic Training Periodfor Brain Injuries

Calgary, Canada
Any Age
All Sexes
A common problem among children with nervous system disorders is difficulty walking on their own. This has impacts beyond mobility including short and long-term health conditions associated with physical inactivity and different developmental experiences as a result of the mobility impairments. A robotic trainer can both provide rehabilitation and be an assistive device to help compensate for difficulties. Figuring out how to prescribe it is critical to improve daily life for children with significant disabilities. Preliminary use of robotic trainers have shown many benefits, such as better head control and improved independence in transfers, which greatly increases ability to live independently. Additionally, vital functions that are frequently impaired in those with less physical activity, such as sleep and bowel habits, seem to improve. Finally, these children enjoy using them. This project aims to determine who is most likely to benefit from training with a robotic trainer and investigate key details about the dose of training that is needed. Families that are already using or hope to use robotic training need this data to help improve their access to the intervention. Clinicians need this systematic approach to building evidence to ensure a future multi-centre randomized control trial is well designed. This study is needed to help improve the lives of those who live with significant disabilities. The objective is to evaluate the feasibility and impacts of delivering robotic gait training at home. Integral in this study is capturing the user perspectives. This will both provide preliminary evidence-based advice to potential users, their families, and clinicians as well as provide key metrics to design a definitive multi-centre randomized control trial. The investigators will provide robotic gait trainers, specifically Trexo robotic gait trainers, to participants and their families to use in their home communities for 12 weeks to evaluate the feasibility and impacts of intensive robotic gait training in people who cannot walk independently. Assessments will be completed throughout the duration of study, including before, during, and after the training intervention, with the goal of evaluating a wide range of feasibility considerations and impacts from robotic training.
Recruiting
Has No Placebo
Phase-Based Progress Estimates
1
Effectiveness
1
Safety

Manual Wheelchair Skills Trainingfor Cerebral Palsy

Grand Rapids, MI
< 18
All Sexes
Manual wheelchairs (MWCs) are widely used by children with physical disabilities, yet many of these children are unable to use their wheelchair independently. Instead, they depend on others to push them. This dependency results in limited opportunities to decide what they want to do and where they want to go, leading to learned helplessness, social isolation, decreased participation, and restricted involvement in physical activities. Furthermore, unsafe MWC use increases the risk of injury, as highlighted by the 44,300 children treated each year in emergency departments for MWC-related injuries. While independent MWC mobility can positively influence quality of life, MWC skills training must also be provided to promote safe, independent MWC use. The effectiveness of MWC training programs for adults is well established, yet the current standard-of-care does not include MWC skills training for children and research regarding the efficacy of pediatric MWC skills training programs is limited. Skills on Wheels seeks to address these gaps and provide pilot data for a future large-scale, multi-site research project involving a randomized controlled trial. Aim 1 is to explore the influence of Skills on Wheels on children's MWC skills and confidence in their MWC use. Aim 2 is to investigate the influence of Skills on Wheels on children's psychosocial skills, social participation, and adaptive behavior.
Recruiting
Has No Placebo
19 Spina Bifida Clinical Trials Near Me
Calgary, Canada
Grand Rapids, MI
Vancouver, Canada
New York, NY
More Trial Locations
An interactive map to display trial locations for Pediatric Onset of Neuromotor Impairments Lab, Alberta Children's Hospital, Grand Valley State University, The Motion Lab, Sunny Hill Health Centre at BC Children's Hospital, Weill Cornell Medicine, and 24 more locations.
Most Popular References for Spina Bifida Clinical Trials
Frequency
Citation
Top Hospitals for Spina Bifida Clinical Trials
Location
Active Spina Bifida Clinical Trials
All Time Trials for Spina Bifida
First Recorded Spina Bifida Trial
Trials
Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario
2
4
2009
Texas Childrens Hospital, Houston, Texas
2
2
2014
Pediatric Onset of Neuromotor Impairments Lab, Alberta Children's Hospital, Calgary, Alberta
1
1
2022
Top Treatments for Spina Bifida Clinical Trials
Treatment Name
Active Spina Bifida Clinical Trials
All Time Trials for Spina Bifida
First Recorded Spina Bifida Trial
Trials
Robotic Training Period
1
1
2022
Manual Wheelchair Skills Training
1
1
2022
Top Cities for Spina Bifida Clinical Trials
Which phases are most popular for spina bifida clinical trials?
Phase
Active Spina Bifida Clinical Trials
Number of Unique Treatments
Number of Active Locations
Trial List
Most Recent Spina Bifida Clinical Trials
Pediatric Spina Bifida Clinical Trials
Senior Friendly Spina Bifida Clinical Trials

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: August 28th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.